Fred C G J Sweep

The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer

Reuben S Harris, Rachel Isaksson Vogel, John W M Martens, 2016, Science Advances.

The circular RNome of primary breast cancer

Alain Viari, Johan Staaf, Carlos Caldas, 2019, Genome research.

Protein chip based miniaturized assay for the simultaneous quantitative monitoring of cancer biomarkers in tissue extracts

Urs Eppenberger, Michael Pawlak, A. Geurts-Moespot, 2006, Proteomics.

Molecular profiling of platinum resistant ovarian cancer

Maurice P H M Jansen, E. Berns, P. Span, 2006, International journal of cancer.

Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer.

Maxime P Look, R. Vossen, J. Foekens, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer

Maxime P Look, J. Foekens, A. Sieuwerts, 2017, Scientific Reports.

Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?

J. Foekens, P. Span, F. Sweep, 2006, Clinical chemistry.

Carotid Baroreceptor Stimulation, Sympathetic Activity, Baroreflex Function, and Blood Pressure in Hypertensive Patients

Jens Jordan, Jens Tank, Siegfried Eckert, 2010, Hypertension.

Plasma Metanephrine for Assessing the Selectivity of Adrenal Venous Sampling

Gerald Antoch, Graeme Eisenhofer, Holger S Willenberg, 2013, Hypertension.